Corebridge Financial Inc. Has $1.58 Million Stock Position in CorVel Co. (NASDAQ:CRVL)

Corebridge Financial Inc. grew its stake in CorVel Co. (NASDAQ:CRVL) by 178.2% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 14,187 shares of the business services provider’s stock after purchasing an additional 9,088 shares during the period. Corebridge Financial Inc.’s holdings in CorVel were worth $1,578,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds have also modified their holdings of CRVL. Vanguard Group Inc. grew its position in CorVel by 202.1% in the fourth quarter. Vanguard Group Inc. now owns 3,281,649 shares of the business services provider’s stock valued at $365,116,000 after acquiring an additional 2,195,466 shares during the period. Boston Trust Walden Corp boosted its stake in shares of CorVel by 196.8% in the 4th quarter. Boston Trust Walden Corp now owns 690,053 shares of the business services provider’s stock valued at $76,775,000 after purchasing an additional 457,538 shares in the last quarter. State Street Corp grew its holdings in shares of CorVel by 0.8% in the 3rd quarter. State Street Corp now owns 360,068 shares of the business services provider’s stock worth $117,703,000 after purchasing an additional 2,959 shares during the last quarter. Charles Schwab Investment Management Inc. increased its position in shares of CorVel by 203.4% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 261,644 shares of the business services provider’s stock worth $29,111,000 after purchasing an additional 175,408 shares in the last quarter. Finally, Geode Capital Management LLC lifted its holdings in CorVel by 3.9% during the 3rd quarter. Geode Capital Management LLC now owns 253,870 shares of the business services provider’s stock valued at $83,000,000 after purchasing an additional 9,571 shares during the last quarter. 51.36% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Separately, StockNews.com cut shares of CorVel from a “buy” rating to a “hold” rating in a research note on Thursday, March 13th.

Insiders Place Their Bets

In other news, Director Jeffrey J. Michael sold 10,477 shares of the firm’s stock in a transaction dated Thursday, February 20th. The shares were sold at an average price of $116.45, for a total value of $1,220,046.65. Following the transaction, the director now owns 568,310 shares of the company’s stock, valued at approximately $66,179,699.50. This trade represents a 1.81 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Alan Hoops sold 10,200 shares of the business’s stock in a transaction that occurred on Tuesday, February 18th. The stock was sold at an average price of $116.39, for a total transaction of $1,187,178.00. Following the sale, the director now directly owns 118,213 shares of the company’s stock, valued at approximately $13,758,811.07. This trade represents a 7.94 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders sold 32,200 shares of company stock valued at $3,824,115. Insiders own 47.57% of the company’s stock.

CorVel Price Performance

CRVL stock opened at $111.50 on Thursday. The stock has a market capitalization of $5.73 billion, a price-to-earnings ratio of 65.59 and a beta of 1.06. The business has a fifty day moving average price of $112.42 and a 200 day moving average price of $114.73. CorVel Co. has a fifty-two week low of $76.20 and a fifty-two week high of $128.61.

CorVel (NASDAQ:CRVL) last announced its earnings results on Tuesday, February 4th. The business services provider reported $0.46 earnings per share for the quarter. CorVel had a return on equity of 32.22% and a net margin of 10.12%.

About CorVel

CorVel Corporation provides workers’ compensation, auto, liability, and health solutions. It applies technology, including artificial intelligence, machine learning, and natural language processing to enhance the managing of episodes of care and the related health care costs. The company also offers network solutions services, including automated medical fee auditing, preferred provider management and reimbursement, retrospective utilization review, facility claim review, professional review, pharmacy, directed care, clearinghouse, independent medical examination, and inpatient medical bill review services, as well as Medicare solutions.